Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We advised Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
Oruka Therapeutics collaboration with Halozyme
We advised Oruka Therapeutics on the transaction
Esentia $600 million revolving credit facility
We advised Esentia on the transaction
Bombardier $500 million senior notes offering
We advised the initial purchasers on the notes offering
PayPal Holdings $2 billion notes offering
We advised the underwriters on the offering
BBVA $2.25 billion contingent convertible securities and senior notes offerings
We advised BBVA on its offerings
Purdue Pharma completes chapter 11 restructuring
We advised Purdue in connection with its nearly seven year-long chapter 11 restructuring
Bolivia $1 billion sovereign bond issuance
We advised Bolivia on the offering
First Eagle Holdings $575 million debut senior secured notes offering
We advised the initial purchasers on the high-yield notes offering
IREN $3 billion convertible notes offering
We advised IREN on the offering
GH Research $200 million at-the-market offering
We advised GH Research on the establishment of the at-the-market program